featured
Quantitative Susceptibility Mapping for Identifying the Pathological Lesion Types in MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A new advanced MRI biomarker for remyelinated lesions in Multiple Sclerosis
Ann. Neurol 2022 Jun 17;[EPub Ahead of Print], R Rahmanzadeh, R Galbusera, PJ Lu, E Bahn, M Weigel, M Barakovic, J Franz, TD Nguyen, P Spincemaille, S Schiavi, A Daducci, F La Rosa, M Absinta, P Sati, MB Cuadra, EW Radue, D Leppert, J Kuhle, L Kappos, W Brück, DS Reich, C Stadelmann, Y Wang, C GranzieraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.